Aprepitant
Who holds supplier records for Aprepitant? 16 organisations hold a current record for Aprepitant: an active US FDA Type II Drug Master File or a CEP. 11 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (8), China (5), Spain (1), Italy (1) and 1 other country (1).
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Aprepitant: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/aprepitant
Reading the evidence
- 16 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- 8 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Aprepitant expires 18 Sept 2035. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (16)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Aprepitant. Country is the organisation's recorded country, not necessarily the manufacturing site.
- MSN PHARMACHEM PRIVATE LTDIndiaCEPActive DMF 29121, 24835, 27214 · latest filing Mar 2015
- Wisdom Pharmaceutical Co., LtdChinaCEPActive DMF 38059, 33175, 44033 · latest filing Apr 2026
- ALIVUS LIFE SCIENCES LTDIndiaCEP Company GMP cert on recordActive DMF 27610, 20381 · latest filing Jan 2014
- Hetero Drugs LimitedIndiaCEP Company GMP cert on recordActive DMF 25572 · latest filing Dec 2011
- INKE SASpainCEPActive DMF 35497 · latest filing Apr 2022
- JUBILANT BIOSYS LTDIndiaCEPActive DMF 26852 · latest filing Mar 2013
- Piramal Pharma LimitedIndiaCEP Company GMP cert on recordActive DMF 26065 · latest filing May 2012
- Shandong Anxin Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 39641 · latest filing Mar 2024
- SOLARA ACTIVE PHARMA SCIENCES LTDIndiaCEP Company GMP cert on recordActive DMF 29215 · latest filing Mar 2015
- Viwit Pharmaceutical Co., Ltd.ChinaCEPActive DMF 33266, 25715, 28866 · latest filing Mar 2019
- Dr. Reddy's Laboratories Ltd.India Company GMP cert on recordActive DMF 21345 · latest filing Feb 2008
- MAHI DRUGS PRIVATE LIMITEDIndiaActive DMF 40624 · latest filing Oct 2024
- OLON SPAItaly Company GMP cert on recordActive DMF 27784 · latest filing Dec 2013
- Pharmathen S.A.Greece Company GMP cert on recordActive DMF 32203 · latest filing Dec 2017
- Sichuan Kelun Pharmaceutical Co., Ltd.ChinaActive DMF 39344 · latest filing Dec 2025
- Chengdu EASTON Biopharmaceuticals Co., Ltd.ChinaCEP
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (11)
Certificates of Suitability on the EDQM register for Aprepitant, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 13 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| SHANDONG ANXIN PHARMACEUTICAL CO., LTD Jinan | CN | CEP 2024-456 - Rev 01 Aprepitant, Form I, milled | Oct 2026 | Inspected Sept 2023 Austria, outside 3-year window |
| ALIVUS LIFE SCIENCES LIMITED Mumbai | IN | CEP 2022-365 - Rev 02 Aprepitant | May 2026 | — |
| WISDOM PHARMACEUTICAL CO., LTD. Haimen | CN | CEP 2019-117 - Rev 01 Aprepitant | Oct 2025 | — |
| JUBILANT BIOSYS LIMITED Nanjangud | IN | CEP 2017-051 - Rev 02 Aprepitant | Sept 2025 | — |
| HETERO DRUGS LIMITED Hyderabad | IN | CEP 2017-196 - Rev 03 Aprepitant | Mar 2025 | — |
| VIWIT PHARMACEUTICAL CO. LTD Tengzhou | CN | CEP 2019-025 - Rev 02 Aprepitant | Feb 2025 | — |
| SOLARA ACTIVE PHARMA SCIENCES LIMITED Chennai | IN | CEP 2022-033 - Rev 00 Aprepitant, Form I | Jan 2025 | — |
| INKE, S.A. Castellbisbal | ES | CEP 2022-247 - Rev 00 Aprepitant, Micronised and non micronised | Oct 2024 | Inspected Mar 2023 Spain, outside 3-year window |
| PIRAMAL PHARMA LIMITED Digwal Village | IN | CEP 2017-192 - Rev 03 Aprepitant, Form-I | May 2024 | Inspected Jun 2025 Netherlands |
| CHENGDU EASTON BIOPHARMACEUTICALS CO., LTD. Chengdu | CN | CEP 2021-323 - Rev 00 Aprepitant | Jan 2024 | — |
| MSN PHARMACHEM PRIVATE LIMITED Sangareddy District | IN | CEP 2021-434 - Rev 01 Aprepitant, Route code AP | Oct 2023 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (14 listed products contain Aprepitant). The latest listed patent expires 18 Sept 2035. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Aprepitant is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1471).
Chemical identity
- IUPAC name
- 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one
- Canonical SMILES
- C[C@H](C1=CC(=CC(=C1)C(F)(F)F)C(F)(F)F)O[C@@H]2[C@@H](N(CCO2)CC3=NC(=O)NN3)C4=CC=C(C=C4)F
- InChIKey
- ATALOFNDEOCMKK-OITMNORJSA-N
- Synonyms
- APONVIE, Aponvie, APREPITANT`, Aprepitant, APREPITANT, APREPITANT (MK-0869), CINVANTI, Cinvanti, EMEND, Emend, L-754,030, L-754030
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Substance P/Neurokinin-1 Receptor Antagonist
- Mechanism of action
- Cytochrome P450 2C9 Inducers; Cytochrome P450 3A4 Inducers; Cytochrome P450 3A4 Inhibitors; Neurokinin 1 Antagonists
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Aprepitant?
16 organisations hold an active US FDA Type II Drug Master File or a CEP for Aprepitant: MSN PHARMACHEM PRIVATE LTD (India), Wisdom Pharmaceutical Co., Ltd (China), ALIVUS LIFE SCIENCES LTD (India), Hetero Drugs Limited (India), INKE SA (Spain), JUBILANT BIOSYS LTD (India), Piramal Pharma Limited (India) and Shandong Anxin Pharmaceutical Co., Ltd. (China), and 8 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Aprepitant Drug Master Files are active?
MSN PHARMACHEM PRIVATE LTD (DMF 29121, 24835), Wisdom Pharmaceutical Co., Ltd (DMF 38059, 33175), ALIVUS LIFE SCIENCES LTD (DMF 27610, 20381), Hetero Drugs Limited (DMF 25572), INKE SA (DMF 35497), JUBILANT BIOSYS LTD (DMF 26852), Piramal Pharma Limited (DMF 26065) and Shandong Anxin Pharmaceutical Co., Ltd. (DMF 39641) and 7 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
Does Aprepitant have a European Certificate of Suitability?
Yes. 11 organisations hold a valid CEP for Aprepitant on the EDQM register, including SHANDONG ANXIN PHARMACEUTICAL CO., LTD Jinan (CN), ALIVUS LIFE SCIENCES LIMITED Mumbai (IN), WISDOM PHARMACEUTICAL CO., LTD. Haimen (CN), JUBILANT BIOSYS LIMITED Nanjangud (IN), HETERO DRUGS LIMITED Hyderabad (IN) and VIWIT PHARMACEUTICAL CO. LTD Tengzhou (CN) and 5 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Aprepitant?
Yes. The latest patent listed for an approved US product containing Aprepitant expires 18 Sept 2035, across 14 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Aprepitant supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Aprepitant?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.